Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000906305-98-000007
Filing Date
1998-01-23
Accepted
1998-01-23 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 CELTRIX PHARMACEUTICALS, INC. SCHEDULE 13D SC 13D/A 9596
  Complete submission text file 0000906305-98-000007.txt   11665
Mailing Address 3055 PATRICK HENRY DRIVE SANTA CLARA CA 95054
Business Address 3055 PATRICK HENRY DR SANTA CLARA CA 95054 4089882500
CELTRIX PHARMACEUTICALS INC (Subject) CIK: 0000871395 (see all company filings)

EIN.: 943121462 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-41502 | Film No.: 98511566
SIC: 2834 Pharmaceutical Preparations

Mailing Address 354 PEQUOT AVE SOUTHPORT CT 06490
Business Address 354 PEQUOT AVE SOUTHPORT CT 06490 2032540091
DAWSON SAMBERG CAPITAL MANAGEMENT INC /CT (Filed by) CIK: 0000906305 (see all company filings)

EIN.: 061033494 | State of Incorp.: CT | Fiscal Year End: 1231